BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 210 filers reported holding BRIDGEBIO PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $43,362,617 | +73.8% | 1,644,392 | +13.4% | 0.03% | +106.2% |
Q2 2023 | $24,943,716 | -4.2% | 1,450,216 | -7.6% | 0.02% | -11.1% |
Q1 2023 | $26,026,372 | +146.6% | 1,569,745 | +13.3% | 0.02% | +125.0% |
Q4 2022 | $10,553,159 | -33.6% | 1,384,929 | -13.3% | 0.01% | -27.3% |
Q3 2022 | $15,887,000 | +18.7% | 1,598,261 | +8.4% | 0.01% | +10.0% |
Q2 2022 | $13,387,000 | +16.6% | 1,474,402 | +30.4% | 0.01% | +42.9% |
Q1 2022 | $11,480,000 | -43.2% | 1,131,040 | -6.7% | 0.01% | -36.4% |
Q4 2021 | $20,222,000 | -9.6% | 1,212,338 | +154.1% | 0.01% | -15.4% |
Q3 2021 | $22,359,000 | -41.7% | 477,043 | -24.2% | 0.01% | -43.5% |
Q2 2021 | $38,366,000 | +3.2% | 629,360 | +4.3% | 0.02% | -4.2% |
Q1 2021 | $37,169,000 | -3.3% | 603,400 | +11.7% | 0.02% | +4.3% |
Q4 2020 | $38,424,000 | +41.0% | 540,353 | -25.6% | 0.02% | +27.8% |
Q3 2020 | $27,255,000 | +3.1% | 726,408 | -10.4% | 0.02% | -14.3% |
Q2 2020 | $26,441,000 | +679.1% | 810,813 | +592.8% | 0.02% | +600.0% |
Q1 2020 | $3,394,000 | +288.3% | 117,038 | +368.8% | 0.00% | +200.0% |
Q4 2019 | $874,000 | +4061.9% | 24,963 | +2386.4% | 0.00% | – |
Q3 2019 | $21,000 | – | 1,004 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 6,068,125 | $55,099,000 | 39.31% |
M28 Capital Management LP | 466,200 | $4,233,000 | 4.74% |
Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $282,034,000 | 3.75% |
Octagon Capital Advisors LP | 933,743 | $8,478,000 | 2.26% |
VIKING GLOBAL INVESTORS LP | 26,620,991 | $241,719,000 | 1.11% |
HHLR ADVISORS, LTD. | 5,362,014 | $48,687,000 | 1.04% |
Cormorant Asset Management, LP | 1,469,179 | $13,340,000 | 1.01% |
Knott David M Jr | 213,206 | $1,936,000 | 0.81% |
Fernwood Investment Management, LLC | 183,900 | $1,670,000 | 0.72% |
HighVista Strategies LLC | 105,942 | $962,000 | 0.58% |